
UBC®Rapid Is Sensitive in Detecting High-Grade Bladder Urothelial Carcinoma and Carcinoma in situ in Asian Population
Author(s) -
Zhijiang Zang,
Nisha Kesavan,
Kesavan Esuvaranathan
Publication year - 2022
Publication title -
urologia internationalis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.771
H-Index - 53
eISSN - 1423-0399
pISSN - 0042-1138
DOI - 10.1159/000526763
Subject(s) - medicine , bladder cancer , cytology , urine cytology , urology , urine , carcinoma in situ , urinary bladder , malignancy , carcinoma , population , pathology , cancer , gastroenterology , environmental health
Bladder cancer is a common type of malignancy. UBC®Rapid is a novel immunoassay detecting urine cytokeratin 8/18 protein. Studies have shown good accuracy of UBC®Rapid in detecting bladder cancer. UBC®Rapid has however to date not been evaluated in Asian patients. We evaluated UBC®Rapid in detecting Asian bladder cancer, together with urine cytology.